| |
IAG Hires Add Pharma Expertise
IAG Research, a US-based advertising effectiveness ratings agency, is expanding its Pharmaceutical Division with the appointments of Senior VP Scott Schappell and VP Fariba Zamaniyan.
Zamaniyan was formerly VP of Marketing and Business for Ipsos Health, where she specialised in consumer research in the pharmaceutical sector, specifically monitoring consumer responses to direct-to-consumer (DTC) advertising for prescription drugs. Zamaniyan gained her health sector expertise as the founder of Ipsos' syndicated DTC consumer-tracking tool PharmTrends. Previously, she specialised in research for the consumer products industry.
Schappell joins from Catalina Health Resource where he was General Manager of Sales. Prior to this, he was Director of Sales for Helios Health, a company installing Internet-connected patient education kiosks in doctors' waiting rooms. Previously, Schappell worked on the Augmentin Marketing Team at SmithKline Beecham. He began his career at Merck & Co in sales and account management.
Schappell and Zamaniyan will be responsible for leading and building the company's work with the pharmaceutical sector. 'Scott and Fariba are important additions to the growing IAG team, bringing deep pharmaceutical sector experience in both sales and market research,' said Alan Gould, Founder and co-CEO of IAG Research. 'Their background and expertise will enable IAG to expand our relationships with pharma, life science and bio companies and help these industries measure the effectiveness of advertising, product placement and promotions.'
IAG Research measures the effectiveness of television advertising, product placement and cinema advertising. The company is online at www.iagr.net
|
